Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

First phase IIa patients receive BrachySil for liver cancer

June 17, 2004

Symadex enters phase I in patients with advanced solid tumors

June 17, 2004

First patient enrolled in phase I/II study of TheraCIM hR3 for pediatric glioma

June 17, 2004

ZYC-101a shows 100% efficacy in patients with high-grade cervical dysplasia

June 17, 2004

Antitumor effects and safety of rhLF in advanced cancer patients

June 17, 2004

Novogen patent discloses isoflavonoid-based antiproliferative agents

June 16, 2004

New antitumor agents developed by Sanofi-Synthelabo scientists

June 16, 2004

Two series of mitotic kinesin KSP inhibitors claimed by Merck

June 16, 2004

Delayed tumor progression found with atrasentan in prostate cancer

June 16, 2004

ARRY-142886 enters phase I trial for advanced cancer

June 16, 2004

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...